Clinical trial · Interventional
REM (Risk Of Endometrial Malignancy)
REM (Risk Of Endometrial Malignancy): A Proposal for a New Scoring System to Evaluate Risk of Endometrial Malignancy
NCT01830192CI-TRIAL-00010030REMcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study was to obtain a predictive model to asses the Risk of Endometrial Malignancy (REM) in women with ultrasound endometrial abnormalities.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Disease | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Training set | Other | — | UNRESOLVED |
| VERIFICATION SET | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Training set
- description
- We evaluate the clinical, ultrasound and laboratory features to predict endometrial cancer disease preoperative
- interventionNames
- Other: Training set
- type
- OTHER
- label
- VERIFICATION SET
- description
- We evaluate the clinical, ultrasound and laboratory features to predict endometrial cancer disease preoperative
- interventionNames
- Other: VERIFICATION SET
Primary outcomes (1)
- measure
- REM (RISK OF ENDOMETRIAL MALIGNANCY): a proposal for a new scoring system to evaluate risk of endometrial malignancy.
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 45 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. aged between 45 and 80 years; 2. Eastern Cooperative Oncology Group performance status 0-2 according to World Health Organization (WHO) criteria; 3. informed consent obtained from the patients. Exclusion Criteria: 1. abnormal cardiac, haematological, renal, respiratory and/or hepatic functions; 2. presence of a previous malignancy; 3. presence of concomitant adnexal masses.
References
Publications (0)
Data not yet available
No reference posted for this study.